Mother Science is a technology company.
Mother Science has raised $10.0M across 2 funding rounds.
Mother Science has raised $10.0M in total across 2 funding rounds.
Mother Science has raised $10.0M in total across 2 funding rounds.
Mother Science's investors include Female Founders Fund, Greycroft, Long Journey Ventures, Drew Houston, Accomplice, Amazon Alexa Fund, Gutter Capital, Innovation Endeavors, Interlace Ventures, Primetime Partners, StartHer, Anne Wojcicki.
Mother Science is a biotechnology beauty brand that develops clinical skincare solutions, primarily a patented serum targeting hyperpigmentation, sun damage, fine lines, and uneven skin tone using the proprietary ingredient Malassezin, a naturally occurring molecule on the skin that's 10x more powerful as an antioxidant than vitamin C.[1][2][5] It serves consumers seeking science-backed skincare, solving problems like dark spots and texture issues through data-driven, efficacious formulations vetted to EU standards.[1][5] Founded in 2021 in Santa Monica, California, the company has raised $15.17M total, including a $3.5M convertible note round about 8 months ago, indicating strong early growth momentum in the biotech beauty space.[1]
Mother Science was founded in 2021 by Mike Einziger, founding guitarist of the rock band Incubus, and his wife, violinist Ann Marie Simpson-Einziger, who were not initially planning a skincare venture.[5] The idea emerged in 2016 when Ann Marie developed a harmless skin condition during a tour, sparking her curiosity that led to the discovery of Malassezin after deep research into skin science.[5] This personal quest evolved into a biotech brand focused on next-generation skincare, quickly gaining traction with clinical proof, patents, and $15.17M in funding by advancing innovative, science-led products.[1][2][5]
Mother Science rides the biotech-beauty convergence trend, where advanced science like patented molecules and clinical validation meet consumer skincare demands, amid rising interest in personalized, efficacious products over influencer-driven trends.[1][2][5] Timing aligns with post-pandemic growth in at-home clinical treatments and clean beauty, fueled by market forces like aging populations, UV awareness, and demand for antioxidant powerhouses amid climate-driven skin stress.[1][5] It influences the ecosystem by democratizing biotech innovations—previously siloed in pharma—into DTC beauty, inspiring similar science-first brands and elevating standards for ingredient transparency and proof-of-results.[2]
Mother Science is poised to expand its Malassezin-powered lineup, potentially into full routines or new actives, leveraging its $15M+ funding for scaling production, global reach, and further clinical trials.[1] Trends like AI-skin diagnostics, sustainable biotech sourcing, and premium clean beauty will shape its path, with potential for partnerships or acquisitions by larger beauty-tech players. As biotech skincare matures, its influence could redefine "gold standard" actives, turning a personal discovery into an industry benchmark—proving curiosity-driven science delivers transformative skin health.[5]
Mother Science has raised $10.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $4.0M Seed | Female Founders Fund, Greycroft, Long Journey Ventures, Drew Houston | |
| Oct 1, 2022 | $6.0M Seed | Accomplice, Amazon Alexa Fund, Female Founders Fund, Gutter Capital, Innovation Endeavors, Interlace Ventures, Long Journey Ventures, Primetime Partners, StartHer, Anne Wojcicki, Arash Ferdowsi, Kyle Vogt, Trevor McFedries, Whitney Wolfe Herd |